BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28819451)

  • 1. A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors.
    Yun M; Kim DY; Lee JJ; Kim HS; Kim HS; Pyo A; Ryu Y; Kim TY; Zheng JH; Yoo SW; Hyun H; Oh G; Jeong J; Moon M; Min JH; Kwon SY; Kim JY; Chung E; Hong Y; Lee W; Kim HS; Min JJ
    Theranostics; 2017; 7(10):2620-2633. PubMed ID: 28819451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
    Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
    Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanofitin as a New Molecular-Imaging Agent for the Diagnosis of Epidermal Growth Factor Receptor Over-Expressing Tumors.
    Goux M; Becker G; Gorré H; Dammicco S; Desselle A; Egrise D; Leroi N; Lallemand F; Bahri MA; Doumont G; Plenevaux A; Cinier M; Luxen A
    Bioconjug Chem; 2017 Sep; 28(9):2361-2371. PubMed ID: 28825794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging reveals trastuzumab-induced epidermal growth factor receptor downregulation in vivo.
    Ma T; Sun X; Cui L; Gao L; Wu Y; Liu H; Zhu Z; Wang F; Liu Z
    J Nucl Med; 2014 Jun; 55(6):1002-7. PubMed ID: 24732154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex Vivo and In Vivo Noninvasive Imaging of Epidermal Growth Factor Receptor Inhibition on Colon Tumorigenesis Using Activatable Near-Infrared Fluorescent Probes.
    Ding S; Blue RE; Moorefield E; Yuan H; Lund PK
    Mol Imaging; 2017; 16():1536012117729044. PubMed ID: 28884622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically functionalized ferritin nanoparticles with a high-affinity protein binder for immunoassay and imaging.
    Kim JW; Heu W; Jeong S; Kim HS
    Anal Chim Acta; 2017 Oct; 988():81-88. PubMed ID: 28916107
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Kruziki MA; Case BA; Chan JY; Zudock EJ; Woldring DR; Yee D; Hackel BJ
    Mol Pharm; 2016 Nov; 13(11):3747-3755. PubMed ID: 27696863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules.
    Garousi J; Andersson KG; Mitran B; Pichl ML; Ståhl S; Orlova A; Löfblom J; Tolmachev V
    Int J Oncol; 2016 Apr; 48(4):1325-32. PubMed ID: 26847636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    Tseng JC; Narayanan N; Ho G; Groves K; Delaney J; Bao B; Zhang J; Morin J; Kossodo S; Rajopadhye M; Peterson JD
    PLoS One; 2017; 12(8):e0182689. PubMed ID: 28792505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance.
    Wehrenberg-Klee E; Turker NS; Heidari P; Larimer B; Juric D; Baselga J; Scaltriti M; Mahmood U
    J Nucl Med; 2016 Sep; 57(9):1413-9. PubMed ID: 27081168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor.
    Goetz M; Ziebart A; Foersch S; Vieth M; Waldner MJ; Delaney P; Galle PR; Neurath MF; Kiesslich R
    Gastroenterology; 2010 Feb; 138(2):435-46. PubMed ID: 19852961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator.
    Andersson KG; Oroujeni M; Garousi J; Mitran B; Ståhl S; Orlova A; Löfblom J; Tolmachev V
    Int J Oncol; 2016 Dec; 49(6):2285-2293. PubMed ID: 27748899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Matrix Metalloproteases in Spontaneous Colon Tumors: Validation by Correlation with Histopathology.
    Hensley H; Cooper HS; Chang WL; Clapper ML
    Methods Mol Biol; 2017; 1579():245-255. PubMed ID: 28299741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors.
    Abourbeh G; Dissoki S; Jacobson O; Litchi A; Ben Daniel R; Laki D; Levitzki A; Mishani E
    Nucl Med Biol; 2007 Jan; 34(1):55-70. PubMed ID: 17210462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and biological evaluation of 3-[(76)Br]bromo-α-methyl-L-tyrosine, a novel tyrosine analog for positron emission tomography imaging of tumors.
    Ohshima Y; Hanaoka H; Watanabe S; Sugo Y; Watanabe S; Tominaga H; Oriuchi N; Endo K; Ishioka NS
    Nucl Med Biol; 2011 Aug; 38(6):857-65. PubMed ID: 21843782
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Jain A; Kameswaran M; Pandey U; Prabhash K; Sarma HD; Dash A
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4552-4557. PubMed ID: 28893469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection.
    Tjalma JJ; Garcia-Allende PB; Hartmans E; Terwisscha van Scheltinga AG; Boersma-van Ek W; Glatz J; Koch M; van Herwaarden YJ; Bisseling TM; Nagtegaal ID; Timmer-Bosscha H; Koornstra JJ; Karrenbeld A; Kleibeuker JH; van Dam GM; Ntziachristos V; Nagengast WB
    J Nucl Med; 2016 Mar; 57(3):480-5. PubMed ID: 26678613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispecific Antibody Conjugated Manganese-Based Magnetic Engineered Iron Oxide for Imaging of HER2/neu- and EGFR-Expressing Tumors.
    Wu SC; Chen YJ; Wang HC; Chou MY; Chang TY; Yuan SS; Chen CY; Hou MF; Hsu JT; Wang YM
    Theranostics; 2016; 6(1):118-30. PubMed ID: 26722378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer.
    Fozing T; Scheuer C; Samnick S
    Eur J Med Chem; 2010 Sep; 45(9):3780-6. PubMed ID: 20538380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of (68)Ga-DOTA-hEGF for visualization of EGFR expression in malignant tumors.
    Velikyan I; Sundberg AL; Lindhe O; Höglund AU; Eriksson O; Werner E; Carlsson J; Bergström M; Långström B; Tolmachev V
    J Nucl Med; 2005 Nov; 46(11):1881-8. PubMed ID: 16269603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.